資料下載
Data download
熱門搜索：
Fitzgerald Industries International代理
Envirologix 轉(zhuǎn)基因快速檢測(cè)試紙
Epitomics現(xiàn)貨抗體目錄
ABgene代理30
EVE™ Slide（EVE細(xì)胞計(jì)數(shù)板）
Cayman Chemical 特約代理
法國(guó)ID-VET
Sinobio公司產(chǎn)品介紹
美國(guó)Sutter 玻璃毛坯 BF100-50-10
polysciences公司中國(guó)總代理
genview
Abcam代理
D12079BWestern Diet(高純度飼料)
TEAA Solution（貨號(hào)：553303;SP5890）
LSPN-50ABMI公司LYSOSTAPHIN中國(guó)總代理
天然小鼠補(bǔ)體C1q蛋白
發(fā)布時(shí)間：2025/12/10
點(diǎn)擊次數(shù)：168
美國(guó)CellMosaic生物公司是生物偶聯(lián)技術(shù)領(lǐng)域的創(chuàng)新先鋒，CellMosaic自2008年由黃玉梅博士創(chuàng)立以來，便以“推動(dòng)生物偶聯(lián)技術(shù)邊界"為使命，專注于高質(zhì)量、創(chuàng)新型高級(jí)生物偶聯(lián)物的研發(fā)與產(chǎn)業(yè)化，其核心產(chǎn)品和服務(wù)廣泛應(yīng)用于科研工具、診斷試劑及抗體藥物偶聯(lián)物（ADCs）等新型治療藥物領(lǐng)域，成為藥企和科研機(jī)構(gòu)信賴的合作伙伴。公司總部位于美國(guó)馬薩諸塞州波士頓，依托該地區(qū)濃厚的生物科技氛圍，構(gòu)建了從技術(shù)研發(fā)到商業(yè)化生產(chǎn)的完整體系，同時(shí)通過布局的研發(fā)與生產(chǎn)基地，快速響應(yīng)市場(chǎng)需求。
作為生物偶聯(lián)技術(shù)創(chuàng)新者，CellMosaic的核心競(jìng)爭(zhēng)力源于在創(chuàng)新連接子設(shè)計(jì)、高效交聯(lián)技術(shù)及規(guī)模化偶聯(lián)工藝三大領(lǐng)域的深厚積累。公司提出利用天然糖醇（SA）單體化學(xué)組裝新型交聯(lián)試劑和聚合物載體的概念，研發(fā)出獨(dú)特的AqT®生物偶聯(lián)平臺(tái)，該平臺(tái)生產(chǎn)的連接劑可與疏水藥物穩(wěn)定結(jié)合，有效解決ADC藥物偶聯(lián)后易聚集沉淀的行業(yè)痛點(diǎn)，相比傳統(tǒng)聚乙二醇（PEG）載體，在親水性、負(fù)載能力、多功能性和定制化方面展現(xiàn)出顯著優(yōu)勢(shì)。這一技術(shù)突破不僅為ADC藥物開發(fā)提供了全新解決方案，也讓CellMosaic在ADC藥物研發(fā)支持領(lǐng)域占據(jù)了重要地位。
CellMosaic的業(yè)務(wù)體系圍繞三大核心板塊展開，形成了覆蓋生物偶聯(lián)全產(chǎn)業(yè)鏈的服務(wù)能力。首先是生物偶聯(lián)試劑與試劑盒系列，其明星產(chǎn)品PerKit®抗體偶聯(lián)試劑盒憑借高效便捷的優(yōu)勢(shì)備受青睞，該試劑盒可實(shí)現(xiàn)IgG抗體或F(ab')?片段與MMAE、SN38、Deruxtecan等多種小分子藥物的精準(zhǔn)偶聯(lián)，實(shí)驗(yàn)人員在實(shí)驗(yàn)室一天內(nèi)即可完成操作，且操作時(shí)間不足2小時(shí)，最終產(chǎn)出的ADC產(chǎn)物純度高達(dá)90%以上，單次可獲得1-3mg產(chǎn)物，滿足從早期研發(fā)到臨床前研究的多樣化需求。同時(shí)配套提供的還有蛋白藥物偶聯(lián)試劑盒、ADC穩(wěn)定存儲(chǔ)試劑、HPLC分析標(biāo)準(zhǔn)品等，形成了全面的ADC解決方案。
其次是定制化偶聯(lián)服務(wù)，CellMosaic可根據(jù)客戶需求量身打造個(gè)性化生物偶聯(lián)方案，涵蓋從早期研發(fā)到臨床前生產(chǎn)的全流程支持，無論是特殊小分子與抗體的偶聯(lián)優(yōu)化，還是特定生物聚合物偶聯(lián)物的定制合成，都能憑借專業(yè)技術(shù)團(tuán)隊(duì)提供精準(zhǔn)服務(wù)。第三大業(yè)務(wù)板塊是合同開發(fā)與制造（CDMO）服務(wù)，公司依托的生產(chǎn)設(shè)施和嚴(yán)格的質(zhì)量管理體系，為制藥企業(yè)提供從工藝開發(fā)到商業(yè)化生產(chǎn)的端到端服務(wù)，助力創(chuàng)新ADC管線快速實(shí)現(xiàn)轉(zhuǎn)化落地。此外，公司還通過戰(zhàn)略合作模式，與藥企聯(lián)合開發(fā)專屬的AqT®生物偶聯(lián)物及ADC管線，進(jìn)一步拓展技術(shù)應(yīng)用邊界。
自成立以來，CellMosaic憑借技術(shù)創(chuàng)新和服務(wù)質(zhì)量贏得了行業(yè)廣泛認(rèn)可，2010年被麻省理工學(xué)院評(píng)為新英格蘭“值得關(guān)注的五家初創(chuàng)公司"之一，2016年榮獲馬薩諸塞州生物醫(yī)學(xué)倡議（MBI）和MassBio頒發(fā)的Joseph R. Carter創(chuàng)新獎(jiǎng)。公司的研發(fā)實(shí)力也得到機(jī)構(gòu)肯定，曾獲得美國(guó)國(guó)家普通醫(yī)學(xué)科學(xué)研究所（NIGMS/NIH）的I期SBIR撥款，用于G蛋白偶聯(lián)受體（GPCR）的標(biāo)記、交聯(lián)及檢測(cè)技術(shù)研究。在市場(chǎng)布局上，CellMosaic通過與艾美捷科技等專業(yè)機(jī)構(gòu)合作，建立了完善的中國(guó)區(qū)代理體系，讓CellMosaic試劑和生物偶聯(lián)服務(wù)更便捷地觸達(dá)中國(guó)科研工作者。
如今，CellMosaic的產(chǎn)品和服務(wù)已覆蓋多個(gè)國(guó)家和地區(qū)，其產(chǎn)品包括CM11409抗體MMAE偶聯(lián)試劑盒、CM51101 hIgG1-MMAF ADC對(duì)照品、CM02022 ADC穩(wěn)定存儲(chǔ)試劑等，同時(shí)提供HIC HPLC分析、SEC HPLC分析等配套檢測(cè)服務(wù)，形成了“試劑+服務(wù)+技術(shù)支持"的一體化模式。未來，CellMosaic將繼續(xù)深耕生物偶聯(lián)技術(shù)領(lǐng)域，聚焦下一代精準(zhǔn)醫(yī)療產(chǎn)品的開發(fā)，為健康事業(yè)的進(jìn)步貢獻(xiàn)力量，也持續(xù)為中國(guó)客戶提供更優(yōu)質(zhì)的CellMosaic生物偶聯(lián)方案。
關(guān)鍵詞：cellmosaic，cellmosaic上海代理，cellmosaic中國(guó)代理，cellmosaic北京代理，cellmosaic江蘇代理， cellmosaic廣東代理、CellMosaic、CellMosaic生物公司、美國(guó)CellMosaic、生物偶聯(lián)技術(shù)創(chuàng)新者、ADC藥物研發(fā)支持、PerKit抗體偶聯(lián)試劑盒、AqT生物偶聯(lián)平臺(tái)、CellMosaic試劑、生物偶聯(lián)服務(wù)、ADC解決方案、CellMosaic中國(guó)代理、抗體藥物偶聯(lián)物、CellMosaic試劑盒、生物偶聯(lián)技術(shù)、ADC穩(wěn)定試劑、CellMosaic CDMO服務(wù)、生物偶聯(lián)定制服務(wù)、CellMosaic創(chuàng)新連接劑、ADC對(duì)照品、CellMosaic生物偶聯(lián)方案
特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購(gòu)買相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用?。?！本次報(bào)價(jià)有效時(shí)間為2025年12月10日---2026年12月14日。
（*此為部分產(chǎn)品價(jià)格,完整價(jià)格請(qǐng)下載文件）
貨號(hào) | 品名 | 規(guī)格 | 價(jià)格 | 品牌 |
CM52144-1x2MG | Maleimide Activated BSA ML 2MG | 2mg | 2539.2 | cellmosaic |
CM52144-3x2MG | Maleimide Activated BSA ML 3x2MG | 3x2mg | 6127.2 | cellmosaic |
CM52109-1x2mg | Maleimide Activated KLH HL 1x2MG | 2mg | 3036 | cellmosaic |
CM52109-3x2mg | Maleimide Activated KLH HL 3x2MG | 6mg | 7212.8 | cellmosaic |
CM52114-1x2MG | Maleimide Activated Ova HL 2MG | 2mg | 2815.2 | cellmosaic |
CM52114-3x2MG | Maleimide Activated Ova HL 3x2MG | 6mg | 6734.4 | cellmosaic |
CM90006 | Maleimide Assay Kit with Purification | 5Assays | 4839.2 | cellmosaic |
CM90002 | Maleimide Assay Kit | 10Assays | 2760 | cellmosaic |
CM11031.1 | MMAE Control Set for In Vitro Studies | ea | 3440.8 | cellmosaic |
CM11032.1 | MMAF Control Set for In Vitro Studies | ea | 3440.8 | cellmosaic |
CM29307-25MG | Novokinin 25MG | 25mg | 4600 | cellmosaic |
CM29307-5MG | Novokinin 5MG | 5mg | 2208 | cellmosaic |
CM52414 | Perkit HRP-Protein Conjugation Kit (HMW) | 1reaction | 14388.8 | cellmosaic |
CM52415 | Perkit HRP-Protein Conjugation Kit (LMW) | 1Reaction | 14388.8 | cellmosaic |
CM52412 | PerKit KLH Small Molecule Acid Conjugation Kit | 5mg | 13763.2 | cellmosaic |
CM52411x1 | PerKit KLH-peptide conjugation kit 1 reaction | 1Reaction | 7040 | cellmosaic |
CM52411x3 | PerKit KLH-peptide conjugation kit 3 reactions | 3Reactions | 16139.2 | cellmosaic |
CM52419 | PerKit Ova Small Molecule Acid Conjugation Kit | 1Reaction | 12438.4 | cellmosaic |
CM52418x1 | PerKit Ova-peptide conjugation kit 1 reaction | 1Reaction | 5860.8 | cellmosaic |
CM52418x3 | PerKit Ova-peptide conjugation kit 3 reactions | 3Reactions | 13428.8 | cellmosaic |
CM11430x1 | Perkit Protein SN38 Conjugation Kit 1 Reaction | 1Reaction | 20961.6 | cellmosaic |
CM11430x3 | Perkit Protein SN38 Conjugation Kit 3 Reactions | 3Reactions | 49878.4 | cellmosaic |
CM32402x1 | PerKit™ Antibody peptide conjugation kit 1 reaction | 1reaction | 9433.6 | cellmosaic |
CM32402x3 | PerKit™ Antibody peptide conjugation kit 3 reactions | 3reactions | 21489.6 | cellmosaic |
CM51403 | PerKit™ Antibody Small Molecule Acid Conjugation kit | 1Reaction | 15548 | cellmosaic |
CM52402x1 | PerKit™ BSA Peptide Conjugation Kit 1 Reaction | 1reaction | 5332.8 | cellmosaic |
CM52402x3 | PerKit™ BSA peptide conjugation kits 3 reactions | 3reactions | 12214.4 | cellmosaic |
CM52403 | PerKit™ BSA Small Molecule Acid Conjugation Kit | 1Reaction | 11076.8 | cellmosaic |
CM52425 | PerKit™ BSA Universal Small Molecule Acid Conjugation Kit | 1Reaction | 11076.8 | cellmosaic |
CM51408 | PerKit™ F(ab')2 Preparation kit (IgG1) 1 reaction | 1Reaction | 7507.2 | cellmosaic |
CM51408x3 | PerKit™ F(ab')2 Preparation kit (IgG1) 3 reactions | 3Reactions | 16438.4 | cellmosaic |
CM51407x3 | PerKit™ Fab Preparation kit (IgG1) 3 reactions | 3Reactions | 16438.4 | cellmosaic |
CM51407x1 | PerKit™ Fab Preparation kit 1 reaction | 1Reaction | 7180.8 | cellmosaic |
CM32401x1 | PerKit™ HRP peptide conjugation kit 1 reaction | 1Reaction | 6248 | cellmosaic |
CM32401x3 | PerKit™ HRP peptide conjugation kit 3 reactions | 3reactions | 14361.6 | cellmosaic |
CM52426 | PerKit™ KLH Universal Small Molecule Acid Conjugation Kit | 1Reaction | 13763.2 | cellmosaic |
CM42301.3x1 | Perkit™ peptide-oligo conjugation kits, ≥60 bases, 1 reaction | 1Reaction | 11510.4 | cellmosaic |
CM42301.3x3 | Perkit™ peptide-oligo conjugation kits, ≥60 bases, 3 reactions | 3Reactions | 26910.4 | cellmosaic |
CM42301.2x1 | Perkit™ peptide-oligo conjugation kits, 31-59 bases, 1 reaction | 1Reaction | 11510.4 | cellmosaic |
CM42301.2x3 | Perkit™ peptide-oligo conjugation kits, 31-59 bases, 3 reactions | 3Reactions | 26910.4 | cellmosaic |
CM42301.1x1 | Perkit™ peptide-oligo conjugation kits, 5-30 bases, 1 reaction | 1Reaction | 11510.4 | cellmosaic |
CM42301.1x3 | Perkit™ peptide-oligo conjugation kits, 5-30 bases, 3 reactions | 3Reactions | 26910.4 | cellmosaic |
CM52408 | Perkit™ Protein Small Molecule Acid Conjugation Kit | 1Reaction | 15548 | cellmosaic |
CM81402-4x250UG | Phenyldiazirine oxLink™ 1 MG | 1milligram | 14204.8 | cellmosaic |
CM81402-250UG | Phenyldiazirine oxLink™ 250UG | 0.25microgram | 4618.4 | cellmosaic |
CM81401-250UG | Phenyldiazirine sxLink™ 250UG | 250 ug pack in box | 4618.4 | cellmosaic |
CM81401-4x250UG | Phenyldiazirine sxLink™ 4x250UG | 1 mg pack in box | 14204.8 | cellmosaic |
CM11432x1 | Protein Deruxtecan Conjugation Kit 1 Reaction | 1Reaction | 25220.8 | cellmosaic |
CM11432x3 | Protein Deruxtecan Conjugation Kit 3 Reactions | 3Reactions | 60068.8 | cellmosaic |
CM11414x1 | Protein Mertansine (DM1) Conjugation Kit 1 Reaction | 1Reaction | 20961.6 | cellmosaic |
CM11414x3 | Protein Mertansine (DM1) Conjugation Kit 3 Reactions | 3Reactions | 49878.4 | cellmosaic |
CM11413x1 | Protein MMAE Conjugation Kit 1 Reaction | 1Reaction | 20961.6 | cellmosaic |
CM11413x3 | Protein MMAE Conjugation Kit 3 Reactions | 3Reactions | 49878.4 | cellmosaic |
AS1005 | Protein PerKit™ Customization for 0.67-6.67 nmol | 1 | 3937.6 | cellmosaic |
CM54201-100UG | R-PE-Streptavidin (1:1) Conjugate, 100 Microgram | 1tube | 4379.2 | cellmosaic |
CM54202-100UG | R-PE-Streptavidin (1:2) Conjugate, 100 Microgram | 1tube | 4379.2 | cellmosaic |
CM54202-500UG | R-PE-Streptavidin (1:2) Conjugate, 500 Microgram | 1tube | 17388 | cellmosaic |
CM54203-100UG | R-PE-Streptavidin HL Conjugate, 100 Microgram | 1tube | 4379.2 | cellmosaic |
CM54203-500UG | R-PE-Streptavidin HL Conjugate, 500 Microgram | 1tube | 17388 | cellmosaic |
CM92005 | SEC (Gel Filtration) HPLC LMW Protein Standard | 1 Pack in Box | 3845.6 | cellmosaic |
CM92004 | SEC (Gel filtration) HPLC Protein Standard (7 components, Lyophilized) | 1Pack | 3845.6 | cellmosaic |
CM11016-1MG | S-methyl DM1 (Mertansine) Standard | 1x1mg | 5372.8 | cellmosaic |
CM11016.1 | S-Methyl DM1 Control Set for In Vitro Studies | 1 | 3440.8 | cellmosaic |
CM11015 | S-methyl DM4 (Ravtansine) Standard | 1mg | 6458.4 | cellmosaic |
CM11034.1 | SN38 Control Set for In Vitro Studies | 1 | 3440.8 | cellmosaic |
CM52420x1 | Streptavidin Antibody Conjugation Kit 1 Reaction | 1Reaction | 12443.2 | cellmosaic |
CM52420x3 | Streptavidin Antibody Conjugation Kit 3 Reactions | 3Reactions | 29110.4 | cellmosaic |
CM52427.2x1 | Streptavidin Oligo Conjugation Kit (Single Label via Click Chemistry), ≥30 bases, 1 reaction | 1Reaction | 14889.6 | cellmosaic |
CM52427.2x3 | Streptavidin Oligo Conjugation Kit (Single Label via Click Chemistry), ≥30 bases, 3 reactions | 1Reaction | 34936 | cellmosaic |
CM52427.1x1 | Streptavidin Oligo Conjugation Kit (Single Label via Click Chemistry), 5-30 bases, 1 reaction | 1Reaction | 14889.6 | cellmosaic |
CM52427.1x3 | Streptavidin Oligo Conjugation Kit (Single Label via Click Chemistry), 5-30 bases, 3 reactions | 1Reaction | 34936 | cellmosaic |
CM52421.3x1 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), ≥60 bases, 1 reaction | 1Reaction | 14889.6 | cellmosaic |
CM52421.3x3 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), ≥60 bases, 3 reactions | 3Reactions | 36784 | cellmosaic |
CM52421.2x1 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), 31-59 bases, 1 reaction | 1Reaction | 13904 | cellmosaic |
CM52421.2x3 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), 31-59 bases, 3 reactions | 3Reactions | 33862.4 | cellmosaic |
CM52421.1x1 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), 5-30 bases, 1 reaction | 1Reaction | 13904 | cellmosaic |
CM52421.1x3 | Streptavidin Oligo Conjugation Kit (Single Label with Amine Oligo), 5-30 bases, 3 reactions | 3Reactions | 33862.4 | cellmosaic |
CM52127-5MG | Sulfadimethoxine-BSA Conjugate HL 5x1 MG | ea | 32273.6 | cellmosaic |
CM52127-1MG | Sulfadimethoxine-BSA Conjugate HL 1MG | ea | 8445.6 | cellmosaic |
CM53101-1x2MG | Thiol Activated HRP (HRP-PEG4-SPDP) 2MG | 2mg | 3845.6 | cellmosaic |
CM53101-3x2MG | Thiol Activated HRP (HRP-PEG4-SPDP) 3x2MG | 2mgx3 | 9255.2 | cellmosaic |
CM90005 | Thiol assay Kit with Purification | 5Assays | 4839.2 | cellmosaic |
CM90004 | Thiol Assay Kit | 10Assays | 2760 | cellmosaic |
CM29202-25MG | Transducin alpha peptide (340-350) 25MG | 25mg | 16983.2 | cellmosaic |
CM29202-5MG | Transducin alpha peptide (340-350) 5MG | 5mg | 5980 | cellmosaic |
CM51000-25UG | Trastuzumab Biosimilar Human anti-HER2 mAb 25 UG | 25mcg | 1656 | cellmosaic |
CM51000-100UG | Trastuzumab Biosimilar Human anti-HER2 mAb, 4 x 25 UG | 100microgram | 3496 | cellmosaic |
當(dāng)前位置：
